One sentence summary: Functional analysis of the multifunctional cytochrome P450 enzyme RosC revealed the catalytic mechanism to form a carboxyl group in the non-active compound 20-carboxyrosamicin.
INTRODUCTION
Cytochrome P450 enzymes (P450s) belong to a very large family of oxidative hemeproteins that are involved in diverse oxidative processes, including xenobiotic catabolism, steroid synthesis and biosynthetic tailoring of diverse natural products. Actinomycetes are one of the most important microorganisms that produce useful secondary metabolites. Genome sequencing of actinomycetes has revealed an unexpectedly large number of genes encoding P450s (Bentley et al. 2002; Ikeda et al. 2003; Oliynyk et al. 2007 ). In the secondary metabolic pathway of actinomycetes, the majority of characterized P450s catalyze region-and stereo-specific oxidation of precursors and lead to structural diversification and modulate bioactivity (Rix et al. 2002) . Recently, some multifunctional P450s have been characterized in biosynthesis of secondary metabolite. MycG catalyzes hydroxylation and epoxidation at C-14 and C-12/13 on the macrolactone ring in mycinamicin biosynthesis pathway of Micromospora griseorubida A11725 (Anzai et al. 2008) . GfsF is responsible for epoxidation and hydroxylation in the biosynthetic pathway of the antibiotic FD-891 produced by Streptomyces graminofaciens (Kudo et al. 2010) . Moreover, TamI catalyzes at least two hydroxylations and epoxidation at three distinct sites (C-10, C-18 and C-11/12) in tirandamycin biosynthesis of Streptomyces sp. 307-9 (Carlson et al. 2011) .
Rosamicin is a 16-member macrolide antibiotic produced by Micromonospora rosaria IFO 13697. It contains a formyl group and an epoxide at the C-20 and C-12/13 positions, respectively. In a recent study, we confirmed that the P450s RosC and RosD catalyze formylation and epoxidation at C-20 and C-12/13 on the macrolactone ring of rosamicin (Iizaka et al. 2013) . In particular, RosC catalyzes a two-step oxidation reaction to form the C-20 formyl group of rosamicin. Moreover, it has been suggested that RosC catalyzes a further oxidation reaction to produce the carboxyl group at C-20, because 20-carboxyrosamicin was detected in culture extracts of M. rosaria (Puar and Schumacher 1990) . In addition, we have reported that 20-dihydrorosamicin, rosamicin and an unknown compound were detected in the bioconversion reaction mixture of 20-deoxo-20-dihydrorosamicin and E. coli TPMB0002, which was expressing RosC (Iizaka et al. 2013) . Mass peaks of the unknown compound were shown at m/z 598 [M+H] + , which is 16 mass units more than those of rosamicin.
In the tylosin biosynthetic pathway, P450 TylI has also been proposed to catalyze hydroxylation and alcohol oxidation at C-20 of 5-mycaminosyl-tylactone (Baltz et al. 1983) . TylI as well as RosC may catalyze a further oxidation reaction of the aldehyde to carboxylic acid because the structure of rosamicin is very similar to that of the tylosin intermediate, O-mycaminosyl tylonolide. The mechanism of carboxylation involving P450 has not been clearly demonstrated in secondary metabolite biosynthesis in actinomycetes. Clarifying the oxidation reaction catalyzed by P450s is a greatly useful information for applications using P450 such as production of novel compounds because functional groups including a carboxyl group influence structural and functional diversity of natural products. In this study, we demonstrated that RosC and TylI catalyze carboxylation at C-20 on rosamicin by bioconversion of rosamicin with E. coli cells overexpressing RosC and TylI and identification of the converted products.
MATERIALS AND METHODS

Construction of plasmids and strains
Most bacterial P450s require an flavin adenine dinucleotide (FAD)-containing ferredoxin reductase to receive the electrons from NAD(P)H, as well as an iron-sulfur-containing ferredoxin, which is the immediate donor of electrons to P450s. However, the native redox system driving the catalytic activity of RosC and TylI remains unknown. Thus, putidaredoxin reductase gene camA and putidaredoxin gene camB derived from Pseudomonas putida were coexpressed with rosC and tylI by using the P450 expression plasmid pCYP-camAB in E. coli cells (Agematu et al. 2006) .
E. coli TPMB0001 and TPMB0002 harboring pCYP-camAB and pRSC-camAB were obtained previously (Iizaka et al. 2013) . pRSC-camAB is a RosC expression plasmid that was constructed by inserting the gene encoding RosC into pCYP-camAB. E. coli TPMB0004 expressing TylI was obtained with the following procedure. The protein-coding regions of tylI were amplified by PCR with primer pairs tylI camAB F/tylI camAB R (5 -GGCATATGACGACACAGACGCTCGAAGCAGAAAAG-3 /5 -GGA CTAGTTCAGTGGCGGGTGACGGTGACCGGAAGCCCG-3 ) using total genomic DNA of Streptomyces fradiae ATCC 19609. The amplified PCR product was cloned into the cloning vector pDrive (Qiagen, Hilden, Germany). After confirming the sequence of the cloned fragment, the 1.2-kb NdeI-SpeI fragment from the recombinant plasmid was inserted into pCYP-camAB to construct pTLI-camAB. The resulting plasmid was introduced into E. coli BL21 (DE3) to obtain E. coli TPMB0004.
Bioconversion of rosamicin with E. coli TPMB0001, TPMB0002 and TPMB0004
Bioconversion reactions were performed using a modified protocol based on the procedure described by Agematu et al. (2006) . E. coli TPMB0001, TPMB0002 and TPMB0004 were cultured at 32
• C overnight with shaking in 2 mL of Luria-Bertani medium containing 50 μg mL −1 ampicillin. Then, 250 μL of the preculture was inoculated into 25 mL of NZCYM medium (1% NZ amine, 0.5% NaCl, 0.5% yeast extract, 0.1% casamino acid and 0.2% MgSO 4 ·7H 2 O, pH 7.0) supplemented with 50 μg mL −1
ampicillin. The E. coli transformants were grown at 37
• C until the OD 600 reached 0.6-0.8, and then 0.1 mM isopropyl-β-Dthiogalactopyranoside and 80 μg mL −1 5-aminolevulinic acid were added, and the E. coli cells were cultured at 22
A 10-fold dilution of each E. coli transformants culture before cell harvest had an OD 600 of 1.4. After collecting cells by centrifugation, each cell pellet of E. coli transformants was suspended in 5 mL of CV buffer (50 mM NaH 2 PO 4 , 1 mM EDTA·2Na, 10% glycerol and 0.2 mM dithiothreitol, pH 7.4). Rosamicin (40 μg mL −1 ) ordered from Sigma-Aldrich was added to 1 mL of the suspension of cells. The cell suspension was incubated at 27
• C for 24 h.
Analytical procedures of bioconversion products
The mentioned bioconversion products were passed through an HP20 sorbent column (Mitsubishi Chemical, Tokyo, Japan). After washing with water, rosamicin derivatives were eluted with methanol (MeOH). The eluate was concentrated to a pasty residue in vacuo. The resulting residue was dried and dissolved in 50 μL of MeOH for high-performance liquid chromatography (HPLC) analysis. HPLC analysis was performed using a diode array detector model L-2450 (Hitachi, Tokyo, Japan) set at 240 nm, fitted with ODS-80TM column (4.6 mm i.d. × 150 mm; Tosoh, Tokyo, Japan) with acetonitrile (MeCN)/0.06% trifluoroacetic acid (TFA) (35:65) as the mobile phase at a flow rate of 0.8 mL min −1 .
Liquid chromatography-mass spectrometry (LC-MS) analysis was performed on LCMS8040 (Shimadzu, Kyoto, Japan) by using a STR ODS-II column (2.0 mm i.d. × 150 mm; Shinwa Chemical Industries, Kyoto, Japan) under the following conditions; mobile phase, MeCN/0.06% TFA (30:70); flow rate, 0.2 mL min −1 ; and detection, UV wavelength at 240 nm.
To isolate and purify 20-carboxyrosamicin, bioconversion of rosamicin (8 mg) with 256-mL suspension of E. coli TPMB0002 was carried out in the same manner. Rosamicin derivatives in the reaction product were absorbed onto a column of HP20 and eluted with MeOH. After the eluate was concentrated to dryness, the residue was dissolved in MeOH and applied to an HPLC system with a Shim-pack PRSP-ODS column (20 mm i.d. × 250 mm; Shimadzu) using the mobile phase MeCN/0.06% TFA (30:70) (flow rate, 10 mL min −1 ) to collect 20-carboxyrosamicin. The fraction containing 20-carboxyrosamicin was concentrated to dryness in vacuo, and 20-carboxyrosamicin (3.6 mg) was obtained. The purified 20-carboxyrosamicin was characterized by high-resolution fast atom bombardment mass spectrometry (HR-FAB-MS) (JMS-700, JEOL, Tokyo, Japan) and 1 H-(500 MHz) and 13 C-(125 MHz) nuclear magnetic resonance (NMR) spectroscopy (JNM-ECP500, JEOL). 
Antibacterial activity of 20-carboxyrosamicin
Antibacterial activities were evaluated by determining minimum inhibitory concentrations (MICs) using the microbroth dilution method with Mueller-Hinton medium (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). After serial dilutions of test compounds were added to a growth medium in 96-well plates, each well was inoculated with Staphylococcus aureus ATCC 25923, Micrococcus luteus ATCC 9341 or E. coli ATCC 25922 and allowed to incubate at 37
• C for 20-24 h. Bacterial growth was evaluated by measurement of the OD 600 . MICs were defined as the lowest concentrations that inhibited 80% of cell growth.
RESULTS
Bioconversion of rosamicin with E. coli cells expressing RosC and TylI
To elucidate the ability of RosC and TylI to form a carboxyl group, bioconversion of rosamicin was performed using E. coli TPMB0001, TPMB0002 and TPMB0004. RosC and TylI were coexpressed with CamA and CamB from Pseudomonas putida as the redox partners to transfer two electrons from NAD(P)H to the heme domain in the cells of E. coli TPMB0002 and TPMB0004, respectively. E. coli TPMB0001 expressed CamA and CamB without a heterologous P450 as a negative control. The reaction mix- tures that included rosamicin and E. coli TPMB0001, TPMB0002 and TPMB0004, respectively, were analyzed by HPLC (Fig. 1) .
A new compound was observed in the reaction mixture using E. coli TPMB0002 and TPMB0004 at 7.1 min, and the UV λmax of the peak was at 240 nm while rosamicin was detected as trace. LC-MS analysis of the compound showed the mass peak at m/z 598 [M+H] + . This mass peak was 16 mass units more than that of rosamicin. Although a small amount of this compound was also detected in the reaction mixture using E. coli TPMB0001, the substrate supplied by Sigma-Aldrich contained small amounts of the compound. In order to confirm the structure of the compound, E. coli TPMB0002 was reacted with rosamicin (8.0 mg). The compound (3.6 mg) was isolated and purified from the reaction products, and its molecular formula was established as C 31 H 51 NO 10 on the basis of
HR-FAB-MS data ([M+Na]
+ found m/z 620.3410, calculated for C 31 H 51 NO 10 Na, 620.3411) (Fig. S1 , Supporting Information). The 1 H-and 13 C-NMR data for this compound were similar to those of 20-carboxyrosamicin reported in the literature (Nakajima et al. 1990; Puar and Schumacher 1990 ) (Figs S2 and S3, Supporting Information). The compound did not exhibit the carbon signal of an aldehyde group at C-20 as observed with rosamicin. Instead, the chemical shift of the compound indicated a carboxyl carbon at 177.9 ppm. From these results, the structure of the compound was identified as 20-carboxyrosamicin. E. coli TPMB0004 as well as E. coli TPMB0002 was reacted with rosamicin, and 2.7 mg of the compound with m/z 598 [M+H] + was isolated and purified. HR-FAB-MS and 1 H-and 13 C-NMR data exhibited the same as those derived from E. coli TPMB0002. RosC and TylI were confirmed to catalyze oxidation of a formyl group at C-20 of rosamicin to a carboxyl group (Fig. 2) .
Comparison of antibacterial activities of rosamicin-analogous compounds formed by RosC
The antibacterial activities of 20-carboxyrosamicin were tested on the Gram-positive bacteria Staphylococcus aureus ATCC 25923 and Micrococcus luteus ATCC 9341 and the Gram-negative bacterium E. coli ATCC 25922, and compared with those of 20-deoxo-20-dihydrorosamicin, 20-dihydrorosamicin and rosamicin (Table 1) . The antibacterial activities of 20-carboxyrosamicin were very similar to those of the same compound reported by Funaishi et al. (1990) . Rosamicin, which possesses a formyl group at C-20, showed significantly higher activity than those of other rosamicin-analogous compounds formed by RosC. Hansen et al. (2002) reported that the ethyl aldehyde at C-6 of 16-membered macrolides forms a covalent bond with bacterial 23S rRNA and plays an important role in antibacterial activity. After RosC catalyzed hydroxylation and alcohol oxidation to form rosamicin, which showed high antibacterial activity, RosC was involved in the formation of 20-carboxyrosamicin, which displayed weak antibacterial activity.
Phylogenetic analysis of RosC and selected bacterial macrolide biosynthetic P450s
In the phylogenetic tree of selected bacterial macrolide biosynthetic P450s (Fig. 3) , RosC was found to be closely related to open reading frame 3 (ORF3) implicated in the rosamicin biosynthesis of Micromonospora carbonacea var. aurantiaca NRRL 2997; TylI, implicated in tylosin biosynthesis; Srm1, implicated in spiramycin biosynthesis and MidM, implicated in midecamycin biosynthesis, all of which are responsible for methyl group formylation of 16-membered ring macrolides. Comparing the deduced amino acid sequences between these enzymes; RosC showed 87% identity with ORF3, 71% with TylI, 63% with Srm1 and 62% with MidM. Therefore, it is expected that Srm1 and MidM also catalyze carboxylation of 16-membered ring macrolides by multistep oxidation. On the other hand, AmphN, FscP, NysN and PimG, which have been presumed to mediate the formation of carboxylic acids in polyene macrolide antibiotics (Aparicio et al. 2003; Carmody et al. 2005; Chen et al. 2009; Brautaset et al. 2011) , constituted a single cluster and were not closely related to RosC and TylI. The deduced amino acid sequences of RosC and these enzymes were less than 30% identity. The mechanism of carboxyl formation in the biosynthesis of polyene macrolide antibiotics has not yet been elucidated.
DISCUSSION
In the post-polyketide synthase tailoring step of macrolide antibiotic biosynthesis, oxidation of the intermediates leads to structural diversity and variation in bioactivities. Oxidation is mainly catalyzed by P450s, whose genes are generally located in the biosynthetic gene cluster. P450s are responsible for the formation of hydroxyl groups, formyl groups, carboxyl groups and epoxy rings in intermediates, and oxidation results in structural diversity in macrolide antibiotics and the synthesis of more complicated molecules. In the present study, E. coli TPMB0002 and TPMB0004 expressing RosC and TylI converted rosamicin into 20-carboxyrosamicin. We confirmed that RosC catalyzes a three-step oxidation reaction, which led to the formation of a hydroxyl group, formyl group and carboxyl group at C-20 of the macrolactone ring in the rosamicin biosynthetic pathway (Fig. 2) . TylI is also expected to show three-step oxidation activity, because TylI has been proposed to catalyze hydroxylation and alcohol oxidation at C-20 of 5-mycaminosyltylactone (Baltz et al. 1983) . Three-step oxidation leading to the formation of a carboxyl group via a hydroxyl and formyl group is catalyzed by several eukaryotic P450s. P450 LTB in the microsomes of human polymorphonuclear leukocytes catalyzes three sequential ω-oxidations of leukotriene B 4 (LTB 4 ), which is a pro-inflammatory mediator, resulting in the formation of 20-COOH-LTB 4 via 20-OH-LTB 4 and 20-CHO-LTB 4 intermediates (Soberman et al. 1988) . Both P450 GA3 from Arabidopsis thaliana and P450-4 from Gibberella fujikuroi catalyze the three steps of gibberellin biosynthesis between ent-kaurene and ent-kaurenoic acid (Helliwell et al. 1999; Tudzynski et al. 2001) .
AmphN, FscP, NysN and PimG, which are involved in the biosynthesis of the polyene macrolides, are P450s that participate in the formation of carboxyl groups. However, the catalytic mechanism of carboxyl formation in polyene macrolide biosynthesis by these P450s is yet to be determined. AmphN, FscP, NysN and PimG belong to a cluster clearly separated from that with RosC and TylI in the phylogenetic tree of P450s involved in macrolide biosynthesis. The clustering of macrolide biosynthetic P450s is considered to correlate with the functionality and substrate size (Anzai et al. 2008) . Rosamicin and tylosin derivatives containing hydroxyl, formyl and carboxyl groups were isolated from the fermentation broths of Micromonospora rosaria and S. fradiae, whereas derivatives of each polyene macrolide antibiotic possessing hydroxyl and formyl groups at the position of the carboxyl group have not been identified in producer strain cultures. Particularly, it has been proven that no hydroxylation tailoring exists in FR-008/candicidin biosynthesis (Chen et al. 2009 ). Carmody et al. (2005) and Chen et al. (2009) have reported that AmphN and FscP may function as dioxydase. Hence, the mechanism of forming carboxyl groups by AmphN, FscP, NysN and PimG may be different from that of RosC and TylI.
Oxidation reactions catalyzed by P450s modulate antibacterial activity in macrolide antibiotic biosynthesis. Rosamicin derivatives formed by RosC showed distinct antibacterial activities (Table 1) . RosC reduced antibacterial activity by converting rosamicin to 20-carboxyrosamicin after RosC participated in the formation of rosamicin, which exhibited high antibacterial activity. RosC plays an important role in the rosamicin biosynthetic pathway of M. rosaria IFO 13697. Formation of a carboxyl group catalyzed by RosC may have a physiological role in detoxification in rosamicin-producing M. rosaria IFO 13697. However, since RosC is also involved in the formation of rosamicin, how RosC controls the multistep oxidation reaction to produce rosamicin derivatives is an intriguing question.
P450s such as RosC and TylI contribute to structural diversification of reaction products. From the findings of this and a previous study (Iizaka et al. 2013 ) about three-step oxidation catalyzed by RosC and two branching pathway from 20-deoxo-20-dihydro-12,13-deepoxyrosamicin, it is assumed that RosC is involved in production of at least six kinds of rosamicin-analogous compounds in M. rosaria IFO13697. Their compounds exhibit different antibacterial activities. It is expected that introducing genes encoding these P450s into heterologous actinomycetes that produce antibiotics will make it possible to produce novel antibiotics with diverse structures and functions. On the other hand, modification by these P450s may result in dispersed production of biosynthetic intermediates. Site-directed mutagenesis of P450s affects not only substrate specificity and catalytic efficiency but also catalytic activity of multiple oxidation (Furuya, Shitashima and Kino 2014) . Moreover, catalytic efficiency and product distribution by P450s are influenced by combination of redox partners that transfer the electrons from NAD(P)H to a P450 (Chun et al. 2007 ). Thus, in order to promote effective production of novel antibiotic compounds, we should estimate amino acid residues involved in the multiple oxidation reactions of RosC and TylI by crystal structural analysis and examine to control product formation by modification of their amino acid residues. Further, the influence on the oxidation reaction by the interaction of RosC or TylI with a variety of redox partner proteins including native them would be investigated.
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